Detalhe da pesquisa
1.
Ketogenic Diet Suppresses Alcohol Withdrawal Syndrome in Rats.
Alcohol Clin Exp Res
; 42(2): 270-277, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29160944
2.
Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.
Behav Pharmacol
; 23(4): 397-406, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22785385
3.
Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.
Behav Pharmacol
; 20(1): 56-66, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19179851
4.
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on ß-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
PLoS One
; 11(7): e0158205, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27421117
5.
Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia.
Pharmacol Biochem Behav
; 95(1): 23-30, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19995568
6.
Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.
Eur J Pharmacol
; 623(1-3): 73-83, 2009 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19765575